Search Results - T. V. Sleptsova

Refine Results
  1. 1

    Jewish Religious and Philosophic Thought through the Lens of Analytical Philosophy by V. V. Sleptsova

    Published 2022-09-01

    The reviewed Jewish Philosophy in an Analytic Age is a unique collection of essays that combine analytical philosophy to the Jewish religion. Analytical approach has been widely applied to Christianity since the 1980s and marked the legitimization of analytical philosophy of religion. This turn is p...

    Full description

    Get full text
    Article
  2. 2

    EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS by Ye. I. Alekseyeva, S. I. Valiyeva, T. V. Sleptsova

    Published 2011-01-01

    The article presents a case report of a patient with juvenile rheumatoid arthritis refractory to the treatment with metothrexate. Combined therapy with metothrexate and leflunomide induced development of unfavorable effects resulted in cancellation of leflunomide. Successful administration of biolog...

    Full description

    Get full text
    Article
  3. 3

    CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by R. V. Denisova, E. I. Alexeeva, T. V. Sleptsova

    Published 2013-09-01

    The article presents a case of successful use of therapeutic monoclonal antibodies to interleukin 1 (canakinumab) at severe systemic juvenile idiopathic arthritis. Canakinumab treatment promptly provided reduction in clinical and laboratory disease activity indicators, increase in life quality, deve...

    Full description

    Get full text
    Article
  4. 4

    A HISTORY CASE OF TOCILIZUMAB USAGE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by R. V. Denisova, E. I. Alexeeva, T. V. Sleptsova

    Published 2012-07-01

    The article represents a history case of successful usage of tolicizumab (anti-interleukin 6 monoclonal antibodies) in treatment of severe systemic juvenile idiopathic arthritis, resistant to previous standard antirheumatic therapy. Tocilizumab treatment led to distal joints function restoration and...

    Full description

    Get full text
    Article
  5. 5

    Experience of etanercept treatment in juvenile ankylosing spondyloarthritis by A. N. Fetisova, E. I. Alexeeva, T. M. Bzarova, T. V. Sleptsova

    Published 2013-03-01

    A history case of severe juvenile ankylosing spondyloarthritis, characterized by rapid development of asymmetric polyarticular syndrome, sacroiliitis, patient’s incapacity and low quality of his and his family life, is discussed in this article. The activity of pathological process was managed to be...

    Full description

    Get full text
    Article
  6. 6

    CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by E. I. Alexeeva, E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova

    Published 2013-07-01

    The article presents a case of successful application of a monoclonal antibodies drug to interleukin 6 receptors (tocilizumab) at severe systemic juvenile idiopathic arthritis with the development of secondary hemophagocytic syndrome. Tocilizumab treatment secured a decrease in clinical and laborato...

    Full description

    Get full text
    Article
  7. 7

    EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS by T. V. Sleptsova, E. I. Alexeeva, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko

    Published 2013-04-01

    The article describes a case with a severe course of oligoarticular juvenile idiopathic arthritis with the development of contracture and destructive articular alterations. The successful use of methotrexate (15mg/m2 of body surface per week, subcutaneously) in a child with early arthritis (disease...

    Full description

    Get full text
    Article
  8. 8

    CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by O. L. Lomakina, E. I. Alexeyeva, R. V. Denisova, T. V. Sleptsova, A. N. Fetisova

    Published 2014-01-01

    The article presents a case of successful use of a preparation of monoclonal antibodies to interleukin 6 receptors (tocilizumab) at asevere systemic juvenile idiopathic arthritis. Tocilizumab treatment promptly provided decrease of clinical and laboratory parametersof the disease activity, increase...

    Full description

    Get full text
    Article
  9. 9

    Experience of Using Tocilizumab in a Patient with Polyarticular Juvenile Rheumatoid Arthritis with Cervical Spine Lesions by E. A. Ligostaeva, N. A. Curikova, E. I. Alekseeva, S. E. Valieva, T. M. Bzarova, T. V. Sleptsova

    Published 2015-11-01

    The article describes a case of polyarticular juvenile idiopathic arthritis lesions of the cervical spine. This clinical example demonstrates the high efficiency of tocilizumab in a patient with polyarticular juvenile idiopathic arthritis with lesions of the cervical spine. After the first injection...

    Full description

    Get full text
    Article
  10. 10

    A CLINICAL EXPERIENCE OF METHOTREXATE USE IN TREATMENT OF PATIENT WITH JUVENILE OLIGOARTHRITIS by K.B. Isaeva, E.I. Alexeeva, R.V. Denisova, T.V. Sleptsova, Т.М. Bzarova

    Published 2011-11-01

    This article presents clinical case of early manifestation of juvenile oligoarthritis with rapid contracture and destructive joint changes formation. Methotrexate was administered IM 15 mg/m2 once a week. After 3 months of treatment — acute inflammatory changes in the joint were relieved as well as...

    Full description

    Get full text
    Article
  11. 11

    THE EXPERIENCE OF PARENTERAL METHOTREXATE TREATMENT IN A PATIENT WITH PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS by T. V. Sleptsova, E. I. Alexeeva, R. V. Denisova, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko

    Published 2012-11-01

    The article contains a history case of early onset of pauciarticular juvenile rheumatoid arthritis resistant to standard immunosuppressive treatment with methotrexate at a dose of 15 mg/m2 per week orally, with development of contractures and destructive changes in the joints. The resistance was suc...

    Full description

    Get full text
    Article
  12. 12

    CLINICAL CASE OF USING TOCILIZUMAB FOR A FEMALE PATIENT WITH AN EARLY DEBUT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by О. L. Lomakina, Ye. I. Alekseyeva, S. I. Valieva, Т. М. Bzarova, R. V. Denisova, Т. V. Sleptsova

    Published 2014-10-01

    The article describes a case of an early debut and difficult treatment of systemic juvenile idiopathic arthritis resistant to peroral glucocorticoids. The described clinical example demonstrates the successful use of tocilizumab, a monoclonal antibody drug, against interleukin-6 receptors. After the...

    Full description

    Get full text
    Article
  13. 13

    EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY AND LATE JUVENILE RHEUMATOID ARTHRITIS by Е.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, R.V. Denisova, A.O. Lisitsyn

    Published 2010-05-01

    The article presents results of a study of effectiveness and safety of infliximab — monoclonal antibodies to the tumor necrotizing factor (TNF) in treatment of 100 patients11 months — 17 years old with early and late articular types of juvenile rheumatoid arthritis. The duration of treatment was 3 m...

    Full description

    Get full text
    Article
  14. 14

    EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA by E. I. Alexeeva, S. I. Valieva, T. M. Bzarova, K. B. Isaeva, R. V. Denisova, T. V. Sleptsova, E. V. Mitenko

    Published 2012-05-01

    A clinical case of severe juvenile scleroderma is represented in this article. The patient had a high activity and aggressive course of disease, he was resistant to steroid, cyclophosphomide and methotrexate therapy in combination with drugs, improving blood circulation. The authors describe the suc...

    Full description

    Get full text
    Article
  15. 15

    PRACTICE OF INFLIXIMAB TREATMENT OF A PATIENT WITH SEVERE POLIARTICULAR JUVENILE RHEUMATOID ARTHRITIS by T.V. Sleptsova, E.I. Alexeeva, T.M. Bzarova, K.B. Isaeva, R.V. Denisova, E.V. Mitenko

    Published 2011-09-01

    This article contains observation of severe poliarticular variant of juvenile rheumatoid arthritis, resistant to glucocorticoid treatment and classic immunosuppressive therapy. There is a description of biologic treatment — with chimeriс antibodies to TNF α — infliximab in a patient with protracted...

    Full description

    Get full text
    Article
  16. 16

    EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS by T. V. Sleptsova, E. I. Alexeeva, R. V. Denisova, S. I. Valieva, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko

    Published 2013-09-01

    The article presents a case of early onset of systemic juvenile arthritis with active articular syndrome, severe systemic manifestations and high level of laboratory disease activity indicators. It describes successful use of methotrexate for intramuscular administration in the dose of 25 mg/m2 of b...

    Full description

    Get full text
    Article
  17. 17

    Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case by E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze

    Published 2016-11-01

    This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal anti-inflammatory drugs, and methotrexate. Just after...

    Full description

    Get full text
    Article
  18. 18

    Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab by T. V. Sleptsova, E. I. Alexeeva, K. V. Savostyanov, A. A. Pushkov, T. M. Bzarova, K. B. Isaeva, R. V. Denisova

    Published 2016-11-01

    The article presents an observation of one of the most common autoinflammatory syndromes — TRAPS (periodic syndrome associated with a mutation in the TNF α receptor gene). During a molecular-genetic examination of a 9-year-old child, a c.337_339del deletion in the heterozygous state of the TNFRSF1A...

    Full description

    Get full text
    Article
  19. 19

    USE OF ETANERCEPT IN PATIENTS WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS by Т. М. Bzarova, Ye. I. Alekseeva, О. L. Lomakina, K. B. Isaeva, S. I. Valieva, R. V. Denisova, Т. V. Sleptsova

    Published 2014-12-01

    The article describes a case of torpid course of oligoarticular juvenile idiopathic arthritis (JIA) and the successful use of soluble receptorsf or tumor necrosis factor alpha (TNF) — etanercept — during its treatment. After 4 weeks of treatment the patient returned to normal laboratory indices of t...

    Full description

    Get full text
    Article
  20. 20

    EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH JUVENILE POLYARTERITIS by E.I. Alexeeva, T.V. Sleptsova, S.I. Valieva, T.M. Bzarova, K.B. Isaeva, R.V. Denisova, E.V. Mitenko

    Published 2011-03-01

    The article presents a case report of severe course of nodular polyarteritis. The disease was highly active, aggressive, and refractory to treatment with corticosteroids and cyclophosphamide combined with plasmapheresis and drugs for microcirculation improvement. The treatment with chimerical anti-C...

    Full description

    Get full text
    Article